Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Claes Wahlestedt

Claes Wahlestedt

individual
Ecosystem influencer

About

Claes Wahlestedt is a Swedish-American biomedical researcher, drug-discovery executive, and biotech entrepreneur. He is Professor and Director of the Center for Therapeutic Innovation at the University of Miami and serves as Associate Dean for Therapeutic Innovation. He is also an advisor to Healthspan Capital and a co-founder and scientific leader at Jupiter Neurosciences.

Areas of interest

biotechdrug discoverygenomicsepigeneticsRNA therapeuticsneuroscienceneurodegenerationlongevity biotechtherapeutic innovation